| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2024 | Jul 1, 2024 | AMARIN CORP PLC\UK | CFO | Sell | 47.5 | -8,209 | -8.01% | ✗ | $5.7K |
| Jun 20, 2024 | Jun 21, 2024 | AMARIN CORP PLC\UK | CFO | Sell | 46.3 | -16,417 | -16.05% | ✗ | $12K |
| Jan 31, 2024 | Feb 2, 2024 | AMARIN CORP PLC\UK | CFO | Sell | 46.3 | -24,552 | -26.26% | ✗ | $30.4K |
| Jan 10, 2024 | Jan 12, 2024 | AMARIN CORP PLC\UK | CFO | Sell | 46.3 | -28,325 | -36.85% | ✗ | $27.5K |
| Jul 1, 2023 | Jul 5, 2023 | AMARIN CORP PLC\UK | CFO | Sell | 47.5 | -8,209 | -24.44% | ✗ | $9.8K |
| Jun 20, 2023 | Jun 22, 2023 | AMARIN CORP PLC\UK | CFO | Sell | 46.3 | -16,417 | -49.25% | ✗ | $19.5K |
| Mar 3, 2022 | Mar 4, 2022 | Tvardi Therapeutics, Inc. | CFO | Sell | 36.3 | -2,044 | -5.13% | ✓ | $23.3K |
| Aug 30, 2021 | Sep 1, 2021 | Tvardi Therapeutics, Inc. | CFO | Sell | 13.8 | -1,982 | -37.16% | ✓ | $28.1K |